On Wednesday, May 10, 2023, the Food and Drug Administration (FDA) announced the publication of a new discussion paper titled “Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products.”The discussion paper aims to facilitate a discussion with…
Source: www.jdsupra.com – Read more
FDA On Use Of AI/ML In Drug Development: Five Key Takeaways | MoFo Life Sciences
Must Read
Why did SentinelOne shares plummet by 35% in a single day?
The highest-valued cybersecurity IPO in history was that of Israel-founded company SentinelOne, which has been managed since its inception by Tomer Weingarten. The offering,...
